• Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant
  • Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant
  • Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant
  • Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant
  • Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant
  • Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant

Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant

Powder: Yes
Customized: Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Adult
State: Powder
Purity: >99%
Samples:
US$ 6/g 1 g(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Product Details
  • Application&Function
  • Specification
Overview

Basic Info.

Model NO.
D-sung Icatibant
Product Name
Icatibant
Name
Icatibant Acetate
Appearance
White Powder
Color
White
Grade
Pharmaceutical Grade
Assay
HPLC 99%
Application
Pharmaceutical
Specific
COA
Test Method
HPLC
Shelf Life
2 Years
CAS No.
138614-30-9
Mf
C59h89n19o13s
MW
1364.593
Density
1.6
Storage
Normal
Transport Package
Negotiable
Specification
99%
Trademark
D-sung
Origin
Shaanxi Xi′an
Production Capacity
500kg/Month

Product Description

Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant
Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate powder Peptide Icatibant
Product Description
Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide IcatibantPharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant
Product Details
Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant
Product name Icatibant
Appearance White powder
CAS NO. 138614-30-9
MF C59H89N19O13S
MW 1364.593
Icatibant is a peptidomimetic drug consisting of ten amino acids, which is a selective and specific antagonist of bradykinin B2 receptors. It has been approved by the European Commission for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults with C1-esterase-inhibitor deficiency.
Application&Function
Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant

A ten-membered synthetic oligopeptide consisting of D-Arg, Arg, Pro, Hyp, Gly, Thi, Ser, D-Tic, Oic, and Arg residues joined in sequrence.
A bradykinin receptor antagonist used as its acetate salt for the treatment of acut attacks of hereditary angioedema in adult patients.

Specification

Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide IcatibantPharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide IcatibantPharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant
Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide IcatibantPharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide IcatibantPharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant
Pharmaceutical Intermediates CAS 138614-30-9 Icatibant Icatibant Acetate Powder Peptide Icatibant


 
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Manufacturer/Factory
Management System Certification
ISO 9001, ISO 14001, GMP, HACCP